BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shiga T, Hiraide M. Cardiotoxicities of 5-Fluorouracil and Other Fluoropyrimidines. Curr Treat Options Oncol 2020;21:27. [PMID: 32266582 DOI: 10.1007/s11864-020-0719-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Wang Z, Qin W, Zhai Z, Huang L, Feng J, Guo X, Liu K, Zhang C, Wang Z, Lu G, Dong S. Use of spectral tracking technique to evaluate the changes in left ventricular function in patients undergoing chemotherapy for colorectal cancer. Int J Cardiovasc Imaging 2021;37:1203-13. [PMID: 33247369 DOI: 10.1007/s10554-020-02103-0] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Clua A, Fàbrega C, García-Chica J, Grijalvo S, Eritja R. Parallel G-quadruplex Structures Increase Cellular Uptake and Cytotoxicity of 5-Fluoro-2'-deoxyuridine Oligomers in 5-Fluorouracil Resistant Cells. Molecules 2021;26:1741. [PMID: 33804620 DOI: 10.3390/molecules26061741] [Reference Citation Analysis]
3 Atashi F, Vahed N, Emamverdizadeh P, Fattahi S, Paya L. Drug resistance against 5-fluorouracil and cisplatin in the treatment of head and neck squamous cell carcinoma: A systematic review. J Dent Res Dent Clin Dent Prospects 2021;15:219-25. [PMID: 34712414 DOI: 10.34172/joddd.2021.036] [Reference Citation Analysis]
4 Hsu PY, Mammadova A, Benkirane-Jessel N, Désaubry L, Nebigil CG. Updates on Anticancer Therapy-Mediated Vascular Toxicity and New Horizons in Therapeutic Strategies. Front Cardiovasc Med 2021;8:694711. [PMID: 34386529 DOI: 10.3389/fcvm.2021.694711] [Reference Citation Analysis]
5 Jain A, Madu CO, Lu Y. Phytochemicals in Chemoprevention: A Cost-Effective Complementary Approach. J Cancer 2021;12:3686-700. [PMID: 33995644 DOI: 10.7150/jca.57776] [Reference Citation Analysis]
6 Adhikari A, Asdaq SMB, Al Hawaj MA, Chakraborty M, Thapa G, Bhuyan NR, Imran M, Alshammari MK, Alshehri MM, Harshan AA, Alanazi A, Alhazmi BD, Sreeharsha N. Anticancer Drug-Induced Cardiotoxicity: Insights and Pharmacogenetics. Pharmaceuticals (Basel) 2021;14:970. [PMID: 34681194 DOI: 10.3390/ph14100970] [Reference Citation Analysis]
7 Saif MW. Alternative Treatment Options in Patients with Colorectal Cancer Who Encounter Fluoropyrimidine-Induced Cardiotoxicity. Onco Targets Ther 2020;13:10197-206. [PMID: 33116601 DOI: 10.2147/OTT.S264156] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Chakwop Ngassa H, Elmenawi KA, Anil V, Gosal H, Kaur H, Mohammed L. Abnormal Dihydropyrimidine Dehydrogenase Activity as an Indicator of Potential 5-Fluorouracil Linked Cardiotoxicity in Colorectal Cancer Patients: Are Toxic Events Inevitable? Cureus 2021;13:e17712. [PMID: 34650886 DOI: 10.7759/cureus.17712] [Reference Citation Analysis]